|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2010-8-31
|
|
pubmed:abstractText |
Based on clinical representation of disease symptoms multiple sclerosis (MScl) patients can be divided into two major subtypes; relapsing remitting (RR) MScl (85-90%) and primary progressive (PP) MScl (10-15%). Proteomics analysis of cerebrospinal fluid (CSF) has detected a number of proteins that were elevated in MScl patients. Here we specifically aimed to differentiate between the PP and RR subtypes of MScl by comparing CSF proteins.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1932-6203
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e12442
|
|
pubmed:meshHeading |
pubmed-meshheading:20805994-Adult,
pubmed-meshheading:20805994-Amino Acid Sequence,
pubmed-meshheading:20805994-Biological Markers,
pubmed-meshheading:20805994-Case-Control Studies,
pubmed-meshheading:20805994-Cerebrospinal Fluid Proteins,
pubmed-meshheading:20805994-Disease Progression,
pubmed-meshheading:20805994-Female,
pubmed-meshheading:20805994-Humans,
pubmed-meshheading:20805994-Male,
pubmed-meshheading:20805994-Middle Aged,
pubmed-meshheading:20805994-Molecular Sequence Data,
pubmed-meshheading:20805994-Multiple Sclerosis,
pubmed-meshheading:20805994-Peptide Fragments,
pubmed-meshheading:20805994-Proteomics,
pubmed-meshheading:20805994-Recurrence
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.
|
|
pubmed:affiliation |
Laboratory of Neuro-Oncology, Department of Neurology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
